Scientia Vascular Highlights Expanded Neurovascular Collaboration With Medtronic

According to a recent LinkedIn post from Scientia Vascular, the company is highlighting its collaboration with Medtronic Neurovascular to integrate Scientia’s access portfolio with Medtronic’s neurovascular treatment therapies. The post frames this as creating a comprehensive neurovascular offering that supports physicians across the full procedural workflow.

The post suggests that Scientia’s technology was involved in treating 90,000 patients in 2025 and implies that Medtronic’s global scale and reach could meaningfully increase that figure over time. For investors, this positioning may indicate potential volume growth, broader market access, and stronger competitive differentiation in neurovascular interventions, though financial terms or specific revenue impacts are not disclosed.